Sanofi Pasteur Korea launches DTaP-IPV combo vaccines

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, says it has launched Tetraxim, a DTaP-IPV combined vaccine as a three-dose primary vaccination at 2, 4 and 6 months of age.

"Our DTaP vaccine will help simplify the immunization schedule by reducing the number of injections infants and young children will receive in their first two years of life," said Emin Turan, President of Sa...